These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8601735)
21. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745 [TBL] [Abstract][Full Text] [Related]
23. High numbers of human skin cancers express MMP2 and several integrin genes. Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742 [TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Kerkelä E; Saarialho-Kere U Exp Dermatol; 2003 Apr; 12(2):109-25. PubMed ID: 12702139 [TBL] [Abstract][Full Text] [Related]
25. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]. Wei QY; Wu YQ; Fan SQ Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069 [TBL] [Abstract][Full Text] [Related]
26. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation. Schoedel KE; Greco MA; Stetler-Stevenson WG; Ohori NP; Goswami S; Present D; Steiner GC Hum Pathol; 1996 Nov; 27(11):1144-8. PubMed ID: 8912822 [TBL] [Abstract][Full Text] [Related]
27. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer. Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026 [TBL] [Abstract][Full Text] [Related]
28. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Terada T; Okada Y; Nakanuma Y Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149 [TBL] [Abstract][Full Text] [Related]
29. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma]. Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531 [TBL] [Abstract][Full Text] [Related]
31. [Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors]. Cai SQ; Chen LR; Wang HJ; Yao LF; Zheng M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):331-4. PubMed ID: 15269985 [TBL] [Abstract][Full Text] [Related]
32. Tissue inhibitor of metalloproteinases-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development. Blavier L; DeClerck YA Mol Biol Cell; 1997 Aug; 8(8):1513-27. PubMed ID: 9285822 [TBL] [Abstract][Full Text] [Related]
33. Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. Kerkelä E; Ala-Aho R; Jeskanen L; Rechardt O; Grénman R; Shapiro SD; Kähäri VM; Saarialho-Kere U J Invest Dermatol; 2000 Jun; 114(6):1113-9. PubMed ID: 10844553 [TBL] [Abstract][Full Text] [Related]
34. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. Airola K; Johansson N; Kariniemi AL; Kähäri VM; Saarialho-Kere UK J Invest Dermatol; 1997 Aug; 109(2):225-31. PubMed ID: 9242512 [TBL] [Abstract][Full Text] [Related]
35. Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer. Joo YE; Seo KS; Kim HS; Rew JS; Park CS; Kim SJ Dig Dis Sci; 2000 Jan; 45(1):114-21. PubMed ID: 10695623 [TBL] [Abstract][Full Text] [Related]
36. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours. Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817 [TBL] [Abstract][Full Text] [Related]
37. Expression of CD44 isoforms in human skin cancer. Simon JC; Heider KH; Dietrich A; Wuttig C; Schöpf E; Adolf GR; Ponta H; Herrlich P Eur J Cancer; 1996 Jul; 32A(8):1394-400. PubMed ID: 8869105 [TBL] [Abstract][Full Text] [Related]
38. Integrins and basement membrane proteins in skin carcinomas. Savoia P; Cremona O; Trusolino L; Pepino E; Marchisio PC Pathol Res Pract; 1994 Oct; 190(9-10):950-4. PubMed ID: 7899145 [TBL] [Abstract][Full Text] [Related]
39. [Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors]. Wang Y; Ueda Y; Shimasaki M; Liu N; Wang EH Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):18-23. PubMed ID: 16608644 [TBL] [Abstract][Full Text] [Related]
40. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors. Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]